Pharmaceutical company in
Plan-Les-Ouates
24 companies in Pharmaceutical company based in Plan-Les-Ouates — name and year of registration from the commercial register. The list below shows them all.
All 24 companies in Plan-Les-Ouates
Stragen Pharma SA
Since 1981 · 101–500 empl.
Stragen Pharma SA develops, registers and distributes generic medicines and consumer healthcare products, including niche medicines for hospital use. Its portfolio includes products for oncology, cardiology, neurology and infectious diseases, as well as women’s and family health.
Addex Pharma SA
Since 2002 · 1–10 empl.
Addex Pharma SA is a clinical-stage pharmaceutical company focused on the development and commercialization of orally available small-molecule allosteric modulators for neurological disorders. Its pipeline includes programs such as dipraglurant (mGlu5 NAM), ADX71149 (mGlu2 PAM) and GABAB PAM candidates targeting indications including substance use disorder and chronic cough.
Epithelix Sàrl
Since 2006 · 11–20 empl.
Epithelix Sàrl develops and supplies in vitro reconstituted human respiratory tissue models and associated culture media, including MucilAir™, SmallAir™ and AlveolAir™. The company also provides laboratory testing services (CRO), such as viral and bacterial infection assays, inhalation toxicity testing, nasal spray evaluation and mucociliary endpoint analyses.
APTISSEN SA
Since 2013 · 51–100 empl.
APTISSEN SA offers products for musculoskeletal conditions. Its range includes injectable hyaluronic acid and sorbitol gels for viscosupplementation, as well as a drinkable food supplement for joints.
SYRHATECH SA
Since 2015 · 11–20 empl.
Syrhatech SA is a Contract Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of formulations for the cosmetics and pharmaceutical industries. The core activities include research and development (R&D), formulation, manufacturing and analysis of products. The company also offers technology transfer and batch manufacturing for clients.
Vaccine Formulation Institute SA
Since 2020 · 21–50 empl.
The core activity of Vaccine Formulation Institute (VFI) is the development and provision of adjuvants and vaccine formulations for global health. The company supports the vaccine community by providing adjuvants and formulation expertise, supports the development of adjuvanted vaccines up to industrial scale, and helps donors and funders implement vaccine development programs.
CDC LAB SA
Since 2021 · 11–20 empl.
CDC LAB SA produces and distributes medical cannabis flowers and plant-based pharmaceutical active ingredients and raw materials. Its services include laboratory analysis according to pharmacopoeias, advice on production and analysis, and contract manufacturing of compounded preparations for Swiss pharmacies.
SUBSTIPHARM BIOLOGICS SA
Since 2022 · 11–20 empl.
SUBSTIPHARM BIOLOGICS SA acquires and commercializes vaccines. Its activities focus on expanding regional access to clinically proven vaccines, including vaccines against Japanese encephalitis and Enterovirus 71.
T.R.B. INTERNATIONAL SA
Since 2009 · 21–50 empl.
T.R.B. INTERNATIONAL SA manufactures and distributes pharmaceutical and biotechnological products, with a focus on ophthalmology and rheumatology. Its portfolio includes hyaluronic acid products for dry eye, joint and tendon conditions, as well as arthroscopy.
Atheris SA
Since 2012 · 11–20 empl.
Atheris SA is a life sciences company listed on the BioAlps platform as part of the Western Switzerland ecosystem. The accessible page does not provide further details about its products, services, or core activities.
KBI Biopharma SA
Since 2020 · 101–500 empl.5.0(3)
KBI Biopharma SA provides contract development and manufacturing services for the biopharmaceutical industry. Its activities include cell line, process, analytical and formulation development, product characterization, and clinical and commercial cGMP manufacturing of biologics.
Corsano Health SA
Since 2025 · 21–50 empl.
Corsano Health SA is a MedTech company that develops, manufactures and markets medical‑grade wearable devices and a cloud platform for continuous, real‑time patient monitoring and remote care. Its CardioWatch bracelets measure multiple vital signs (heart rate, respiratory rate, ECG, SpO2, core temperature and cuffless blood pressure), hold CE‑MDR certification and FDA 510(k) clearance, and provide APIs/SDKs and raw data access for clinical research and EMR integration.
Exeltis Suisse SA
Since 2022 · 1–10 empl.
Exeltis Suisse SA distributes medicines for women's health. Its product range includes medicines for contraception, pregnancy and menopause.
NovImmune SA
Since 1998 · 51–100 empl.5.0(1)
The core activity of NovImmune SA is the development of antibodies, in particular natural bispecific antibodies (κλ-bodies), for the treatment of cancer. The company focuses on the development of therapeutics that specifically target tumor cells by targeting specific molecules such as CD47 and CD28.
HEKETISS SA
Since 2021 · 11–20 empl.
HEKETISS SA is a biotechnology company developing regenerative cell therapies for chronic wounds. Its TrophiPatch product is a skin patch containing adipose-derived stem cells and is being evaluated in clinical studies.
B-Hive AG
Since 2026 · 11–20 empl.
B-Hive AG is an engineering and operational consulting company that provides technical assistance, operational support, and project management services to its clients. The company focuses on the Life Sciences and industrial sectors, including pharmaceutical, biotech, medtech, cosmetics, chemicals, and agro-food activities.
MesenFlow Technologies Sàrl
Since 2018 · 1–10 empl.
MATEX LAB SWITZERLAND SA
Since 2019 · 1–10 empl.
Swedish Orphan Biovitrum AG
Since 2019 · 1–10 empl.
NewMol SA
Since 2020 · 1–10 empl.
Alentis Therapeutics SA
Since 2023 · 1–10 empl.
TheraPPI Bioscience SA
Since 2024 · 1–10 empl.
Immitra Bio GmbH
Since 2025 · 1–10 empl.
Nexus Biosolutions SA
Since 2026 · 1–10 empl.
Pharmaceutical company in Plan-Les-Ouates
Pharmaceutical company in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 6, 2026
Pharmaceutical company in other places
By canton